These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1834832)

  • 1. Cell-density dependency in the survival kinetics of neocarzinostatin-treated HeLa cells in monolayer cultures and in spheroids.
    Sasaki T; Kuroda Y; Hoshino F
    J Radiat Res; 1991 Jun; 32(2):202-14. PubMed ID: 1834832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual survival kinetics of neocarzinostatin-treated HeLa cells: its relation to the drug-inactivation.
    Kuroda Y; Sasaki T; Hoshino F
    J Radiat Res; 1991 Jun; 32(2):191-201. PubMed ID: 1834831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of cytotoxicity of zinostatin under acidic conditions in vitro and in vivo.
    Kuroiwa T; Taniguchi S; Aoki K; Hasuda K; Baba T
    Cancer Treat Rep; 1987 Mar; 71(3):247-51. PubMed ID: 2949830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
    Erlichman C; Vidgen D
    Cancer Res; 1984 Nov; 44(11):5369-75. PubMed ID: 6488191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neocarzinostatin-induced DNA strand scission and subsequent cell cycle traverse in HeLa S3 cells.
    Berry DE; Collins JM
    Cancer Res; 1980 Jul; 40(7):2405-10. PubMed ID: 6446380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular action of Neocarzinostatin. Intracellular incorporation, DNA breakdown and cytotoxicity.
    Takeshita J; Maeda H; Koike K
    J Biochem; 1980 Oct; 88(4):1071-80. PubMed ID: 6256337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of blood, ascites, and tumor cell density on cytocidal action of neocarzinostatin.
    Shimoyama M; Kimura K
    Gan; 1979 Apr; 70(2):165-71. PubMed ID: 157307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity and reduced inhibition of DNA synthesis in ataxia telangiectasia lymphoblasts treated with low levels of neocarzinostatin.
    Babilon RW; Soprano KJ; Henderson EE
    Mutat Res; 1985 Jul; 146(1):79-87. PubMed ID: 3158810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal effect of bleomycin and peplomycin on HeLa cells in multicell tumor spheroids.
    Sasaki T; Yamamoto M; Kuwahara K
    Cancer Res; 1984 Apr; 44(4):1374-9. PubMed ID: 6200210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine-induced recovery from G2 block caused by neocarzinostatin.
    Iseki S; Ebina T; Ishida N
    Gan; 1980 Aug; 71(4):567-71. PubMed ID: 6448762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth.
    Müller WE; Maidhof A; Arendes J; Geurtsen W; Zahn RK; Schmidseder R
    Cancer Res; 1979 Sep; 39(9):3768-73. PubMed ID: 89904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione dependence of neocarzinostatin cytotoxicity and mutagenicity in Chinese hamster V-79 cells.
    DeGraff WG; Mitchell JB
    Cancer Res; 1985 Oct; 45(10):4760-2. PubMed ID: 3161610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of caffeine on neocarzinostatin-induced inhibition of cell cycle traverse in HeLa-S3 cells.
    Iseki S; Ebina T; Ishida N
    Cancer Res; 1980 Oct; 40(10):3786-91. PubMed ID: 6449284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery from potentially lethal damage and recruitment time of noncycling clonogenic cells in 9L confluent monolayers and spheroids.
    Rodriguez A; Alpen EL; Mendonca M; DeGuzman RJ
    Radiat Res; 1988 Jun; 114(3):515-27. PubMed ID: 3375440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effect of neocarzinostatin on human lymphoid cells.
    Maeda H; Matsumoto M
    Tohoku J Exp Med; 1979 Aug; 128(4):313-23. PubMed ID: 225845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uptake and localization of neocarzinostatin in malignant glioma. Experimental study by immunofluorescent staining method].
    Otsuka T; Matsukado Y; Uemura S; Kuratsu J; Mihara Y; Yoshioka S; Goto S
    Neurol Med Chir (Tokyo); 1989 Aug; 29(8):689-95. PubMed ID: 2479861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neocarzinostatin (NCS).
    Ishida N; Ebina T
    Jpn J Antibiot; 1977 Dec; 30 Suppl():93-103. PubMed ID: 148519
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular hypersensitivity to neocarzinostatin in ataxia-telangiectasia skin fibroblasts.
    Shiloh Y; Tabor E; Becker Y
    Cancer Res; 1982 Jun; 42(6):2247-9. PubMed ID: 6210429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential neutralizing effect of tiopronin on the toxicity of neocarzinostatin and SMANCS: a new rescue cancer chemotherapy.
    Oda T; Yamamoto H; Miki T; Maeda H
    Jpn J Cancer Res; 1989 Apr; 80(4):394-9. PubMed ID: 2526108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of neocarzinostatin on microtubules.
    Satake M; Ebina T; Ishida N
    Gan; 1979 Aug; 70(4):545-8. PubMed ID: 159849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.